Radionuclide therapy

We offer radionuclide therapy in the following areas:

  • Targeted therapy of neuroendocrine tumors, meningiomas and neuroblastomas
  • Radioiodine therapy for thyroid diseases
  • selective internal radiotherapy (SIRT) of liver tumors or metastases
  • Radiosynoviorthesis of painful joints
  • Targeted therapy of castration-resistant prostate carcinoma
  • Radionuclide therapy of bone metastases in prostate cancer
  • Radioimmunotherapy for lymphomas

Selective internal radio therapy (SIRT) is a minimally invasive method for treating liver tumors. It uses the blood supply to the tumors. A catheter is inserted through a small incision in the groin via the bloodstream into the liver vessels. The therapeutic substance is then administered there - small radioactively labeled particles which, due to their size, get stuck mainly in the blood vessels of the liver tumors and achieve strong local irradiation of the tumor tissue.

The treatment is offered in cooperation between Nuclear Medicine and Interventional Radiology at the Department of Radiology and Nuclear Medicine. Last year, the SIRT program was re-initiated at the University Hospital Basel with the option of outpatient treatment.

Further information can be found in the following Swiss television video: